Analysis of costimulation by 4-IBBL, CD40L, and B7 in graft rejection by gene expression profiles

Journal of Molecular Medicine

Volumn 81, Issue 10, 2003, Pages 655-663

  DeFina, Rachel ^a   Christopher, Kenneth ^a   He, Hongzhen ^a   Mandelbrot, Didier ^b   Gu, Yongping ^a   Finn, Patricia ^a   Perkins, David L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Chemokine; Cytokines; Gene expression; Transplantation

Indexed keywords

CD137 LIGAND; CD28 ANTIGEN; CD40 LIGAND; GENE PRODUCT; RIBONUCLEASE; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION;

4-1BB LIGAND; ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; ANTIGENS, CD28; ANTIGENS, CD40; ANTIGENS, CD86; CD40 LIGAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENES, RAG-1; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RIBONUCLEASE, PANCREATIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242351597     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-003-0468-1     Document Type: Article

References (20)

1. Pearson TC, Alexander DZ, Corbascio M, Hendrix R, Ritchie SC, Linsley PS, Faherty D, Larsen CP (1997) Analysis of the B7 costimulatory pathway in allograft rejection. Transplantation 63:1463-1469
2. Turka LA, Linsley PS, Lin H, Brady W, Leiden JM, Wei RQ, Gibson ML, Zheng XG, Myrdal S, Gordon D, et al (1992) T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 89:11102-11105
3. Kirk AD, Harlan DM, Armstrong NN, Davis DA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH Jr, Knechtle SJ (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 94:8789-8794
4. Fu WL, Zhang BX, Mo HG (1993) Monitoring and control of infection in patients after renal transplantation. Chin Med J (Engl) 106:674-678
5. Kwon B, Moon CH, Kang S, Seo SK, Kwon BS (2000) 4-1BB: still in the midst of darkness. Mol Cells 10:19-126
6. Watts TH, DeBenedette MA (1999) T cell co-stimulatory molecules other than CD28. Curr Opin Immunol 11:286-293
7. DeBenedette MA, Wen T, Bachmann MF, Ohashi PS, Barber BH, Stocking KL, Peschon JJ, Watts TH (1999) Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 163:4833-4841
8. Bluestone JA (1996) Costimulation and its role in organ transplantation. Clin Transplant 10:104-109
9. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-438
10. Corry RJ, Winn HJ, Russell PS (1973) Heart transplantation in congenic strains of mice. Transplant Proc 5:733-735
11. Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacoby D, Strom TB, Simpson EM, Freeman GJ, Sharpe AH (1997) B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303-313
12. Scaria A, St George JA, Gregory RJ, Noelle RJ, Wadsworth SC, Smith AE, Kaplan JM (1997) Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Ther 4:611-617
13. Hallensleben W, Biro L, Sauder C, Hausmann J, Asensio VC, Campbell IL, Staeheli P (2000) A polymorphism in the mouse crg-2/IP-10 gene complicates chemokine gene expression analysis using a commercial ribonuclease protection assay. J Immunol Methods 234:149-151
14. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:14863-14868
15. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR (1999) Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A 96:2907-2912
16. Mandelbrot DA, Furukawa Y, McAdam AJ, Alexander SI, Libby P, Mitchell RN, Sharpe AH (1999) Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol 163:3753-3757
17. He H, Stone JR, Perkins DL (2002) Analysis of robust innate immune response after transplantation in the absence of adaptive immunity. Transplantation 73:853-861
18. Christopher K, Mueller TF, Ma C, Liang Y, Perkins DL (2002) Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol 169:522-530
19. Shimizu K, Schonbeck U, Mach F, Libby P, Mitchell RN (2000) Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 165:3506-3518
20. Popma SH, Krasinskas AM, Kreisel D, Szeto W, McLean AD, Moore JS, Rosengard BR (2001) Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response. Transplant Proc 33:767-769